{
    "organizations": [],
    "uuid": "2e9dc43bde9685625003b435be18afd41930e179",
    "author": "Imani Moise",
    "url": "https://www.wsj.com/articles/axovant-stock-tumbles-after-sweeping-leadership-changes-1518452146",
    "ord_in_thread": 0,
    "title": "Axovant Stock Tumbles After Sweeping Leadership Changes",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Axovant Sciences Ltd. made sweeping changes to its top ranks Monday as the company struggles to regain its footing after abandoning its banner Alzheimerâ€™s drug.\nShares plunged 20% to $1.54 during morning trading, and are down 88% from a year ago.\nChief Executive David Hung has resigned after 10 months in his role, but will continue to serve... To Read the Full Story Subscribe Sign In",
    "published": "2018-02-12T21:09:00.000+02:00",
    "crawled": "2018-02-13T08:50:02.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "axovant",
        "science",
        "made",
        "sweeping",
        "change",
        "top",
        "rank",
        "monday",
        "company",
        "struggle",
        "regain",
        "footing",
        "abandoning",
        "banner",
        "alzheimer",
        "drug",
        "share",
        "plunged",
        "morning",
        "trading",
        "year",
        "ago",
        "chief",
        "executive",
        "david",
        "hung",
        "resigned",
        "month",
        "role",
        "continue",
        "serve",
        "read",
        "full",
        "story",
        "subscribe",
        "sign"
    ]
}